Description

Bufezolac is a non-steroidal anti-inflammatory drug (NSAID) belonging to the oxicam class, known for its potent analgesic and anti-inflammatory properties. This compound is a key intermediate in the synthesis of active pharmaceutical ingredients (APIs) for treating pain and inflammation. It is essential for pharmaceutical manufacturers and research institutions developing new therapeutic formulations. Bufezolac CAS NO 50270-32-1 is valued for its specific pharmacological activity and role in advanced drug development pipelines.

Application

• Pharmaceutical Intermediate: Primary use as a critical building block in the synthesis of finished NSAID APIs.
• Analgesic Drug Development: Research and production of medications targeting pain management.
• Anti-inflammatory Formulations: Used in the development of drugs to reduce inflammation and swelling.
• Veterinary Medicine: Potential application in anti-inflammatory treatments for animal health.
• Biochemical Research: Serves as a reference standard and tool compound in pharmacological studies.
• Custom Synthesis: Basis for the preparation of novel derivatives and prodrugs in medicinal chemistry.

Basic Information

Product Name	Bufezolac
CAS No.	50270-32-1
Molecular Formula	C₁₆H₁₄N₂O₃
Molecular Weight	282.30 g/mol
Synonyms	Bufezolac; 2-[4-(2-Thiazolyloxy)phenyl]propionic Acid; 4-(1,3-Thiazol-2-yloxy)hydratropic Acid; BFE; Bufezolacum; CCRIS 6681; EINECS 256-464-3; NSC 339539
EINECS	256-464-3

Quality Control

Our Bufezolac is manufactured under strict quality management systems to ensure high purity and batch-to-batch consistency. It is suitable for use in GMP-compliant pharmaceutical synthesis. Comprehensive testing includes identity, purity, and impurity profile analysis. A Certificate of Analysis (COA) detailing all specifications is provided with each shipment to guarantee compliance with your requirements.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (15-25°C). Due to its hygroscopic nature, the container must be kept tightly sealed to minimize exposure to atmospheric moisture. Keep away from incompatible materials.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time matches reference standard
Assay (HPLC)	≥ 98.5%
Related Substances (HPLC)	Total impurities ≤ 1.0%
Any single unknown impurity	≤ 0.5%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.